Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio of two proteins, pTau217 and ß-Amyloid 1-42, which are implicated in ...

Dr. Rahul Biswas is mapping how the brain’s networks break down in disease, using artificial intelligence to turn those ...

Dr. Ausim Azizi is among those seeing the overall early results, as Yale New Haven Hospital is in the forefront of research ...

When we think of autism, we might think about younger people. Autism wasn’t formally recognized as a diagnosable condition ...

In the brain on the left the disease is in a stable state, while in the brain on the right the disease is Slowly Progressive. The AI model developed by the team can tell these apart precisely.

Artificial intelligence (AI) models trained on large datasets are increasingly seen as the key to unlocking personalized ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...

RUHX, the official charity of the Royal United Hospitals (RUH) Bath, has launched a £4 million appeal to fund a new PET-CT scanner, which will improve early diagnosis and treatment across a range of ...

The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond ...